Praeventix
PrivateLast Round
Series A
Feb 13, 2026
Total Funding Raised
$7.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Praeventix operates in Healthcare & Life Sciences and is based in Exton, Pennsylvania. Its latest recorded funding round was a Series A round in February 2026.
Praeventix is a biotechnology company that develops novel serotonergic therapeutics and signal transduction-modulating agents for the treatment of inflammatory, dermatologic, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Praeventix Comparables
Compare Praeventix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 76% | |
| Turn Therapeutics Inc. | 75% | |
| Alys Pharmaceuticals | 73% |
For institutional investors. Book with your work email.
Praeventix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2026 | ||||
| Seed Round | Feb 3, 2026 | ||||
| Early Funding | May 8, 2025 | ||||
| Seed | Nov 8, 2022 |
For institutional investors. Book with your work email.
Praeventix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| Tellus BioVentures | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2026
Completed a Series A funding round.
- Feb 3, 2026
Raised $5.6M in a Seed Round.
For institutional investors. Book with your work email.
Praeventix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Praeventix's valuation, stock price, and market status.
Is Praeventix a public or private company?
Praeventix is a private company.
What is the current stock price of Praeventix?
Praeventix is a private company, so its shares have no public market price. Caplight tracks Praeventix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Praeventix worth (valuation)?
Valuation information for Praeventix is not publicly available.
Can I buy Praeventix stock?
Praeventix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Praeventix's last funding round?
Praeventix's most recent funding round was Series A on February 13, 2026.
Who are the main investors in Praeventix?
Key investors in Praeventix include National Institute on Drug Abuse, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Tellus BioVentures, National Institute of Diabetes and Digestive and Kidney Diseases.
Will Praeventix IPO soon?
No public IPO plans have been announced for Praeventix.
How can I track Praeventix secondary market activity?
Caplight tracks bids, offers, and trades in Praeventix's shares on secondary markets.